|
Name |
Hydroxysydonic acid, (+/-)-
|
Molecular Formula | C15H22O5 | |
IUPAC Name* |
4-(2,6-dihydroxy-6-methylheptan-2-yl)-3-hydroxybenzoic acid
|
|
SMILES |
CC(C)(CCCC(C)(C1=C(C=C(C=C1)C(=O)O)O)O)O
|
|
InChI |
InChI=1S/C15H22O5/c1-14(2,19)7-4-8-15(3,20)11-6-5-10(13(17)18)9-12(11)16/h5-6,9,16,19-20H,4,7-8H2,1-3H3,(H,17,18)
|
|
InChIKey |
YCUWMGPYKGLQQF-UHFFFAOYSA-N
|
|
Synonyms |
Hydroxysydonic acid; Sydonic acid, hydroxy-; (+/-)-hydroxysydonic acid; MLS000876960; G7S0F27G2L; Hydroxysydonic acid, (+/-)-; SMR000440676; Benzoic acid, 4-(1,5-dihydroxy-1,5-dimethylhexyl)-3-hydroxy-; 1649441-60-0; UNII-G7S0F27G2L; MEGxm0_000167; CHEMBL1305336; ACon0_000427; ACon1_002047; BDBM82882; cid_16745403; DTXSID001347378; HMS2270G20; NCGC00179884-01; Hydroxysydonic acid, >=95% (LC/MS-ELSD); BRD-A93280656-001-01-8; Q27896520; 4-(1,5-dihydroxy-1,5-dimethyl-hexyl)-3-hydroxy-benzoic acid; 4-(2,6-dihydroxy-6-methylheptan-2-yl)-3-hydroxybenzoic acid; 4-[6-methyl-2,6-bis(oxidanyl)heptan-2-yl]-3-oxidanyl-benzoic acid; NCGC00179884-02!4-(2,6-dihydroxy-6-methylheptan-2-yl)-3-hydroxybenzoic acid; 65967-72-8
|
|
CAS | 1649441-60-0 | |
PubChem CID | 16745403 | |
ChEMBL ID | CHEMBL1305336 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 282.33 | ALogp: | 2.0 |
HBD: | 4 | HBA: | 5 |
Rotatable Bonds: | 6 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 98.0 | Aromatic Rings: | 1 |
Heavy Atoms: | 20 | QED Weighted: | 0.643 |
Caco-2 Permeability: | -4.972 | MDCK Permeability: | 0.00001490 |
Pgp-inhibitor: | 0.004 | Pgp-substrate: | 0.006 |
Human Intestinal Absorption (HIA): | 0.028 | 20% Bioavailability (F20%): | 0.01 |
30% Bioavailability (F30%): | 0.014 |
Blood-Brain-Barrier Penetration (BBB): | 0.1 | Plasma Protein Binding (PPB): | 51.92% |
Volume Distribution (VD): | 0.307 | Fu: | 47.30% |
CYP1A2-inhibitor: | 0.018 | CYP1A2-substrate: | 0.548 |
CYP2C19-inhibitor: | 0.023 | CYP2C19-substrate: | 0.053 |
CYP2C9-inhibitor: | 0.051 | CYP2C9-substrate: | 0.17 |
CYP2D6-inhibitor: | 0.014 | CYP2D6-substrate: | 0.121 |
CYP3A4-inhibitor: | 0.038 | CYP3A4-substrate: | 0.07 |
Clearance (CL): | 5.058 | Half-life (T1/2): | 0.896 |
hERG Blockers: | 0.043 | Human Hepatotoxicity (H-HT): | 0.162 |
Drug-inuced Liver Injury (DILI): | 0.715 | AMES Toxicity: | 0.01 |
Rat Oral Acute Toxicity: | 0.007 | Maximum Recommended Daily Dose: | 0.005 |
Skin Sensitization: | 0.051 | Carcinogencity: | 0.013 |
Eye Corrosion: | 0.004 | Eye Irritation: | 0.438 |
Respiratory Toxicity: | 0.009 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002565 | 1.000 | D05VIX | 0.333 | ||||
ENC002564 | 0.700 | D0BA6T | 0.319 | ||||
ENC002688 | 0.672 | D0K5CB | 0.311 | ||||
ENC005624 | 0.667 | D02ZJI | 0.311 | ||||
ENC004442 | 0.667 | D0P7JZ | 0.306 | ||||
ENC003401 | 0.645 | D0Y6KO | 0.289 | ||||
ENC003302 | 0.625 | D0C4YC | 0.286 | ||||
ENC005625 | 0.594 | D01WJL | 0.286 | ||||
ENC003717 | 0.545 | D0SS4P | 0.276 | ||||
ENC005626 | 0.493 | D08HVR | 0.271 |